Using the electronic health records of over 5 million people aged under 30, researchers from the Oxford Health Biomedical Research Centre found that eating disorders were diagnosed significantly more commonly in 2020 than in previous years, with the rate increasing steadily throughout the year.
Research & Development
There are many ways to get involved with research at Oxford Health NHS Foundation Trust
Results from the Novavax vaccine study recently published in the New England Journal of Medicine have shown the vaccine to have an overall efficacy of 89.7%. The vaccine has also been shown to be 83.4% effective after just one dose and 83.6% effective against the B1.1.7 variant.
Feeling Safe is a new treatment programme for persecutory delusions, which promises a step change in the treatment of severe mental health problems.
A project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) has been successful in the latest round of the Artificial Intelligence in Health and Care Award.
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia and this may be a cause of vaccine hesitancy.
Emeritus Professor Christopher Fairburn, Honorary Consultant Psychiatrist at Oxford Health NHS Foundation Trust, has been appointed to the Order of the British Empire (OBE) in this year’s Birthday Honours List in recognition of his work at the forefront of eating disorder research for over 30 years
Professor John Geddes will step down as the Director of Research and Development at Oxford Health later this month after 10 years.
May is Stroke Awareness month, and this year the Stroke Association is focusing on research and its importance for improving patient outcomes after stroke.
Watch our short film introducing the NIHR Oxford cognitive health Clinical Research Facility – meet the people who work there and find out more about what they do and how you can get involved.
This International Nurses’ Day, Dr Cathy Henshall, Head of Research Delivery at Oxford Health and Reader in the Oxford School of Nursing and Midwifery (OSNM), talks about preparing the next generation of nurses for roles in patient care and research.
A new study has reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, and several times higher than it is post-vaccination or following influenza.
A new study shows 1 in 3 survivors of COVID-19 received a neurological or psychiatric diagnosis within 6 months. The risk was greater in people who had severe COVID-19, but 1 in 9 patients not requiring hospitalisation, also received a diagnosis.